Tag Archives: COVID-19

New Data on Advance Care Planning During Pandemic Coincides with Preparations for Healthcare Decisions Day

As the toll of COVID-19 continues to climb, newly released poll data suggest an opportunity to use the pandemic as a prompt for discussing and documenting older adults’ wishes for  care, in case of seriously illness or injury.

Overall, 59% of the 50- to 80-year-olds polled said they had had a conversation with loved ones about their preferences in case they became severely ill. That percentage was even higher — 70% — among those over age 65. Just 7% of all older adults polled said COVID-19 had motivated them to have such conversations. Continue reading

Baker Administration Announces Vaccine Timeline for All Residents, Provides Weekly Dose Updates & $24.7 Million in Federal Funding for Vaccine Equity Initiative

The Baker Administration announced the timeline for all remaining residents to be eligible for a COVID-19 vaccine.

The Administration also announced the weekly distribution of vaccine doses statewide for providers and a new $24.7 million investment in the Administration’s Vaccine Equity Initiative. Continue reading

Poll Finds Big Shift in High-Risk Older Adults’ Attitudes Toward COVID-19 Vaccination

Last fall, nearly half of older adults were on the fence about COVID-19 vaccination – or at least taking a wait-and-see attitude, according to a University of Michigan poll taken at the time.

But a new follow-up poll shows that 71% of people in their 50s, 60s and 70s are now ready to get vaccinated against COVID-19 when a dose becomes available to them, or had already gotten vaccinated by the time they were polled in late January. That’s up from 58% in October. Continue reading

CDC Offers Interim COVID-19 Safety Guidance for Fully Vaccinated People While Mass Opens Vaccine Pre-Registration System

The Centers for Disease Control and Prevention (CDC) offered the first set of public health recommendations for people fully vaccinated from COVID-19. This guidance will be updated and expanded based on the level of community spread of SARS-CoV-2, the proportion of the population that is fully vaccinated, and the rapidly evolving science on COVID-19 vaccines. Continue reading